NEW YORK, Jan. 25 (GenomeWeb News) - The National Institutes of Health has awarded a five-year, $10 million grant to the University of California, San Francisco and SRI International to study the pharmacogenetics of nicotine addiction and treatment, SRI announced today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.